Ctxr stock forecast.

CTXR Stock Price - Citius Pharmaceuticals Inc. - MarketWatch 0.9050 ; Volume: 582.81K · 65 Day Avg: 1.67M ; 0.8700 Day Range 0.9200 ; 0.7700 52 Week Range 1.7100 ... CTXR : Citius Pharmaceuticals Inc - Stock Price, Quote and News

Ctxr stock forecast. Things To Know About Ctxr stock forecast.

Feb 19, 2021 · CTXR stock was up 23.8% as of Friday morning and is up 84.6% since the start of the year. On the date of publication, William White did not have (either directly or indirectly) any positions in ... Citius Pharmaceuticals - CTXR Stock Forecast, Price & News Analyst's Opinion · Consensus Rating. Citius Pharmaceuticals has received a consensus rating of Buy.Find the latest Citius Pharmaceuticals, Inc. CTXR analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating report typeStock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ... iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock All the information on the website is for reference only. If the user trades according to this information, he/she shall be responsible for any ...

May 4, 2023 · Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care ...

The company’s next reporting date is on May 11, 2023, with an EPS forecast of -$0.04. Its annual revenue for the last year was $0.00, and it had an annual profit of -$33.6M. The net profit margin for CTXR is not available. Citius Pharmaceuticals Inc (CTXR) Targets $6.00 Median Price Forecast, +313.79% Increase – Buy CTXR Stockctxr stock forecast zacks ctxr price target reddit ctxr stock split citius pharmaceuticals why is ctxr stock down ctxr stock forecast 2025 ctxr yahoo finance Popular Search Web Page Citius Pharmaceuticals ($ CTXR ) – THREE products with upcoming ...

Find the latest Earnings Report Date for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Skip to main content ... Read our earnings report guide before you consider the forecast ...Jul 1, 2021 · Shares of Citius Pharmaceuticals ( CTXR 2.84%), a clinical-stage biopharmaceutical company, are getting beaten down today after the company released disappointing news regarding its lead candidate ... Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Apr 17, 2023 · On April 17, 2023 at 15:10:33 ET an unusually large $25.00K block of Call contracts in Citius Pharmaceuticals (CTXR) was bought, with a strike price of $2.50 / share, expiring in 214 day(s) (on ...

Jul 31, 2023 · Citius Pharmaceuticals Inc (CTXR) $0.70 0.01 (1.46%) 16:00 EDT CTXR Stock Quote Delayed 30 Minutes.

Nov 17, 2023 · On Friday, Citius Pharmaceuticals Inc (CTXR:NAQ) closed at 0.7729, 28.82% above the 52 week low of 0.600 set on Oct 24, 2023. 52-week range. Today. 0.600 Oct 24 2023 1.71 Apr 17 2023. Short selling activity.

CTXR - Citius Pharmaceuticals Inc Stock Forecast - StockInvest.us Given the current short-term trend, the stock is expected to fall -15.38% during the next 3 months and, with a 90% probability hold a price between $0.749 and ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below. According to present data Coterra Energy's CTRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.finance.yahoo.com - May 8 at 5:21 PM. Citius Pharmaceuticals Announces $15 Million Registered Direct Offering. finance.yahoo.com - May 4 at 10:04 AM. Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Up 6.5% in April. marketbeat.com - May 2 at 3:49 AM. Citius Pharmaceuticals (CTXR) Gets a Buy from Maxim Group.CTXR Stock Price - Citius Pharmaceuticals Inc. - MarketWatch 0.9050 ; Volume: 582.81K · 65 Day Avg: 1.67M ; 0.8700 Day Range 0.9200 ; 0.7700 52 Week Range 1.7100 ... CTXR : Citius Pharmaceuticals Inc - Stock Price, Quote and NewsCastor Maritime Inc. (NASDAQ:CTRM) announced its quarterly earnings data on Wednesday, November, 8th. The company reported ($0.01) earnings per share for the quarter. The firm earned $21.41 million during the quarter. Castor Maritime had a trailing twelve-month return on equity of 8.37% and a net margin of 33.68%.Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. About the company. CTXR fundamental analysis. Snowflake Score. Valuation. 2 /6.

The average Southwest Airlines Co stock price prediction forecasts a potential upside of 21.83% from the current LUV share price of $26.69. What is LUV's forecast return on equity (ROE) for 2023-2026? (NYSE: LUV) forecast ROE is N/A, which is considered .According to 18 stock analysts, the average 12-month stock price forecast for Chevron stock is $188.72, which predicts an increase of 30.24%. The lowest target is $169 and the highest is $212. On average, analysts rate Chevron stock as a buy.Complete Citius Pharmaceuticals Inc. stock information by Barron's. View real-time CTXR stock price and news, along with industry-best analysis. CTXR Stock Analysis Overview What this means: InvestorsObserver gives Citius Pharmaceuticals Inc (CTXR) an overall rank of 38, which is below average. Citius Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.CTXRCitius Pharmaceuticals IncHot news for this penny stock! Is it time to BUY with huge upside potential!?Let's break down this bad boy and share some smile...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Citius Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

The CTXR stock was last observed hovering at around $0.89 in the last trading session, with the day’s loss setting it -0.09% off its average median price target of $4.00 for the next 12 months. It is also 90.0% off the consensus price target high of $8.00 offered by 3 analysts, but current levels are 80.0% higher than the price target low of …Dec 1, 2023 · Corporate Overview. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. What this means: InvestorsObserver gives Citius Pharmaceuticals Inc (CTXR) an overall rank of 38, which is below average. Citius Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system. Ticker Symbol CTXR Full Company Profile Financial Performance Financial Statements Analyst Forecast According to one analyst, the rating for CTXR stock is …Citius Pharmaceuticals Inc Stock Price Forecast, "CTXR" Predictons for2028 Forecast Crypto Forecasts Top 5 Crypto forecasts Bitcoin forecast Ethereum forecast Xrp forecast Binance Usd forecast Weth forecast Stock Forecasts (US)NSD:CTXR Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes Best Stocks Quickly zoom in on the stocks with highest and lowest potential based on analyst recommendations and

Detailed statistics for Citius Pharmaceuticals, Inc. (CTXR) stock, including valuation metrics, financial numbers, share information and more. Stock Price Statistics The stock price has decreased by -33.62% in the last 52 weeks. The beta is …

Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Cresco Labs Inc have a median target of 2.65, with a high estimate of 12.35 and a low estimate of 1.25. The median ...

Citius Pharmaceuticals Inc (CTXR) Stock Price Today, News, Quotes, FAQs and Fundamentals Home Symbol CTXR CTXR Citius Pharmaceuticals Inc 21,968 $1.49 $0.01 (0.67%) Today $1.47 0.02 (1.34%) Pre-Market Market Cap $219.39M Volume (M) 903.00Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Price target. 14.69 0.00 0.00%. The 6 analysts offering 1 year price forecasts for GTE have a max estimate of — and a min estimate of —.Citius Pharmaceuticals Inc stock price live 0.773, this page displays NASDAQ CTXR stock exchange data. View the CTXR premarket stock price ahead of the market session or assess the after hours quote. Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.14.73R USD +8.41 +133.03%. The 6 analysts offering 1 year price forecasts for Gran Tierra Energy Inc. have a max estimate of 26.17 and a min estimate of 7.33.Stock Price Forecast. According to 13 stock analysts, the average 12-month stock price forecast for Coterra Energy stock is $31.62, which predicts an increase of 15.70%. The lowest target is $27 and the highest is $42. On average, analysts rate Coterra Energy stock as a buy.View real-time CTXR stock price and news, along with industry-best analysis. Citius Pharmaceuticals, Inc. Common Stock ( CTXR ) - Nasdaq Key Data ; Share Volume, 898,308 ; Average Volume, 957,784 ; Previous Close, $1.13 ; …Buy or Hold candidate since Oct 16, 2023 Gain 60.37% PDF. The ESSA Pharma Inc. stock price fell by -1.33% on the last day (Thursday, 16th Nov 2023) from $5.25 to $5.18. During the last trading day the stock fluctuated 5.11% from a day low at $5.09 to a day high of $5.35.

iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock TGP - Teekay LNG Partners L.P. - 相關新聞| 美股| Anue鉅亨 - 基金 Take-Two will acquire Zynga for $12.7 billion in a cash plus stock deal ...SPIR Stock 12 Months Forecast. $25.00. (433.05% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Spire Global in the last 3 months. The average price target is $25.00 with a high forecast of $26.00 and a low forecast of $24.00. The average price target represents a 433.05% change from the last price of $4.69.Citius Pharmaceuticals NasdaqCM:CTXR Stock Report Earnings vs Savings Rate: CTXR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).Instagram:https://instagram. america's credit ratingallegro polandschwab dividend fundmortgage companies new hampshire Citius Pharmaceuticals Stock Forecast. Is Citius Pharmaceuticals Stock Undervalued? The current Citius Pharmaceuticals [ CTXR] share price is $0.78. The Score for CTXR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CTXR is currently trading in the 50-60% percentile range relative to its historical ... best day trading chat roomsnew jersey mortgage companies Citius Pharmaceuticals Market Cap: 150.02M, Enterprise value: N/A, P/E: -6.95, PEG ratio: N/A, EPS: -73309.72, Revenue: N/A, EBITDA: -34.34M, Income: -34.85M, ProfitThe average Viatris stock price prediction forecasts a potential upside of 9.58% from the current VTRS share price of $9.43. What is VTRS's forecast return on equity ... reit investment calculator The company’s next reporting date is on May 11, 2023, with an EPS forecast of -$0.04. Its annual revenue for the last year was $0.00, and it had an annual profit of -$33.6M. The net profit margin for CTXR is not available. Citius Pharmaceuticals Inc (CTXR) Targets $6.00 Median Price Forecast, +313.79% Increase – Buy CTXR StockFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...